Literature DB >> 9451668

Correlation of serum immunoglobulin G Helicobacter pylori antibody titers with histologic and endoscopic findings in patients with dyspepsia.

P I Hsu1, K H Lai, H H Tseng, Y C Liu, M Y Yen, C K Lin, G H Lo, R L Huang, J S Huang, J S Cheng, W K Huang, L P Ger, W Chen, P N Hsu.   

Abstract

Serum immunoglobulin G (IgG) antibody tests are used extensively. We attempted to find out whether the titers of anti-Helicobacter pylori IgG antibody correlated with the degree of macroscopic gastrointestinal damage, the severity of antral gastritis, and the density of antral H. pylori colonization in symptomatic patients. Peripyloric antral biopsy specimens were obtained from 50 consecutive patients with dyspepsia undergoing upper gastrointestinal endoscopy. The macroscopic gastrointestinal damage and the histologic grades of antral gastritis were scored by a modified Lanza scale and Sydney system, respectively. In addition, the densities of antral H. pylori colonization were graded semiquantitatively. Serum IgG antibodies to H. pylori were measured by enzyme-linked immunosorbent assay. Thirty-six (M/F = 29/7) of the 50 patients had H. pylori infection documented by histologic examination or rapid urease test or both. Among the subjects, the IgG antibody titers to H. pylori correlated significantly with the grades of antral polymorphonuclear cell infiltration (p = 0.002) and antral bacterial density (p = 0.01) but not with endoscopic scores, the grades of mononuclear cell infiltration, mucosal atrophy, or intestinal metaplasia (p > 0.05). In addition, endoscopic scores also were found to be significantly correlated with antral bacterial density (p = 0.049) and the grade of polymorphonuclear cell infiltration (p = 0.012). We therefore conclude that high titers of IgG antibody to H. pylori in patients with dyspepsia indicate dense H. pylori colonization and severe antral polymorphonuclear cell infiltration. However, it cannot replace endoscopic examination to evaluate the degree of macroscopic gastrointestinal damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9451668     DOI: 10.1097/00004836-199712000-00007

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  15 in total

1.  Comparative study of serology and histology based detection of Helicobacter pylori infections: a large population-based study of 7,241 subjects from China.

Authors:  Y H Gong; L P Sun; S G Jin; Y Yuan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-05       Impact factor: 3.267

2.  Polymerase chain reaction: a sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers.

Authors:  Ching-Chu Lo; Kwok-Hung Lai; Nan-Jing Peng; Gin-Ho Lo; Hui-Hwa Tseng; Chiun-Ku Lin; Chang-Bih Shie; Chao-Ming Wu; Yu-Shan Chen; Wen-Keui Huang; Angela Chen; Ping-I Hsu
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Implications of anti-parietal cell antibodies and anti-Helicobacter pylori antibodies in histological gastritis and patient outcome.

Authors:  Ching-Chu Lo; Ping-I Hsu; Gin-Ho Lo; Kwok-Hung Lai; Hui-Hwa Tseng; Chiun-Ku Lin; Hoi-Hung Chan; Wei-Lun Tsai; Wen-Chi Chen; Nan-Jing Peng
Journal:  World J Gastroenterol       Date:  2005-08-14       Impact factor: 5.742

4.  Association of the myeloperoxidase -468G-->A polymorphism with gastric inflammation and duodenal ulcer risk.

Authors:  Ping-I Hsu; Jyh-Jen Jwo; Hui-Hwa Tseng; Kwok-Hung Lai; Gin-Ho Lo; Ching-Chu Lo; Chung-Jen Wu; Seng-Kee Chuah; Il-Ran Hwang; Jin-Liang Chen; Yu-Shan Chen; Angela Chen
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern.

Authors:  Kyland P Holmes; John C Fang; Brian R Jackson
Journal:  BMC Health Serv Res       Date:  2010-12-21       Impact factor: 2.655

6.  Gastric juice acidity in upper gastrointestinal diseases.

Authors:  Pei-Jung Lu; Ping-I Hsu; Chung-Hsuan Chen; Michael Hsiao; Wei-Chao Chang; Hui-Hwa Tseng; Kung-Hung Lin; Seng-Kee Chuah; Hui-Chun Chen
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

7.  Helicobacter pylori infection and typhoid fever in Jakarta, Indonesia.

Authors:  A M Vollaard; H W Verspaget; S Ali; L G Visser; R A Veenendaal; H A G H Van Asten; S Widjaja; Ch Surjadi; J T Van Dissel
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

8.  Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.

Authors:  Ping-I Hsu; Deng-Chyang Wu; Jeng-Yih Wu; David Y Graham
Journal:  Helicobacter       Date:  2011-04       Impact factor: 5.753

9.  Immunoglobulin G antibody against Helicobacter pylori: clinical implications of levels found in serum.

Authors:  Tseng-Shing Chen; Fen-Yau Li; Full-Young Chang; Shou-Dong Lee
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

10.  Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients.

Authors:  P-I Hsu; K-H Lai; G-H Lo; H-H Tseng; C-C Lo; H-C Chen; W-L Tsai; H-S Jou; N-J Peng; C-H Chien; J-L Chen; P-N Hsu
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.